NCT00585689 Neoadjuvant ABI-007, Carboplatin and Gemcitabine in Locally Advanced Bladder Cancer Status COMPLETED Phase PHASE2
NCT00583830 A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00583622 Bevacizumab Plus Gemcitabine, Docetaxel, Melphalan, and Carboplatin in Ovarian Cancer Patients Status TERMINATED Phase PHASE2
NCT00581971 Radiosensitization With Celecoxib and Chemoradiation for Head and Neck Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00580983 Optimized Intensity Modulated Irradiation for Head and Neck Cancer Status COMPLETED Phase NA
NCT00578149 Bevacizumab and Carboplatin/Paclitaxel and Radiation in Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00573690 Sorafenib Combined With Cisplatin and Etoposide or Carboplatin and Pemetrexed in Treating Patients With Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT00570674 Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck Status TERMINATED Phase PHASE1/PHASE2
NCT00568451 Paclitaxel and Carboplatin or Temozolomide in Treating Patients With Stage IV Melanoma Status TERMINATED Phase PHASE2
NCT00567567 Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma Status COMPLETED Phase PHASE3
NCT00565851 Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT00564733 FDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00563784 TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2
NCT00562185 Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian Cancer Status WITHDRAWN Phase PHASE1/PHASE2
NCT00561795 Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological Tumors Status COMPLETED Phase PHASE2
NCT00554788 Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma Status COMPLETED Phase PHASE3
NCT00553462 Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery Status COMPLETED Phase PHASE2
NCT00551733 Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE3
NCT00550537 Proteomic Profiling in Predicting Response in Patients Receiving Erlotinib for Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00547443 Sorafenib and High-Dose Carboplatin, Paclitaxel, and External-Beam Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer Status WITHDRAWN Phase PHASE1/PHASE2